Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Two novel tumor suppressor gene loci on chromosome 6q and 15q in human osteosarcoma identified through comparative study of allelic imbalances in mouse and man

Abstract

We have performed a comparative study of allelic imbalances in human and murine osteosarcomas to identify genetic changes critical for osteosarcomagenesis. Two adjacent but discrete loci on mouse chromosome 9 were found to show high levels of allelic imbalance in radiation-induced osteosarcomas arising in (BALB/c×CBA/CA) F1 hybrid mice. The syntenic human chromosomal regions were investigated in 42 sporadic human osteosarcomas. For the distal locus (OSS1) on mouse chromosome 9 the syntenic human locus was identified on chromosome 6q14 and showed allelic imbalance in 77% of the cases. Comparison between the human and mouse syntenic regions narrowed the locus down to a 4 Mbp fragment flanked by the marker genes ME1 and SCL35A1. For the proximal locus (OSS2) on mouse chromosome 9, a candidate human locus was mapped to chromosome 15q21 in a region showing allelic imbalance in 58% of human osteosarcomas. We have used a combination of synteny and microsatellite mapping to identify two potential osteosarcoma suppressor gene loci. This strategy represents a powerful tool for the identification of new genes important for the formation of human tumors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Balmain A, Harris CC . 2000 Carcinogenesis 21: 371–377

  • Balsara BR, Bell DW, Sonoda G, De Rienzo A, du Manoir S, Jhanwar SC, Testa JR . 1999 Cancer Res. 59: 450–454

  • Belchis DA, Meece CA, Benko FA, Rogan PK, Williams RA, Gocke CD . 1996 Diagn. Mol. Pathol. 5: 214–219

  • Bernues M, Casadevall C, Caballin MR, Miro R, Ejarque MJ, Chechile G, Gelabert A, Egozcue J . 1999 Cancer Genet. Cytogenet. 112: 42–45

  • Biegel JA, Womer RB, Emanuel BS . 1989 Cancer Genet. Cytogenet. 38: 89–100

  • Boehnke M, Lange K, Cox DR . 1991 Am. J. Hum. Genet. 49: 1174–1188

  • Bridge JA, Nelson M, McComb E, McGuire MH, Rosenthal H, Vergara G, Maale GE, Spanier S, Neff JR . 1997 Cancer Genet. Cytogenet. 95: 74–87

  • Brinkschmidt C, Blasius S, Burger H, Simon R, Diallo R, Battmann A, Winkelmann W, Bocker W, Dockhorn-Dworniczak B . 1998 Verh. Dtsch. Ges. Pathol. 82: 184–188

  • Chen J, Zhong Q, Wang J, Cameron RS, Borke JL, Isales CM, Bollag RJ . 2001 Mol. Cell Endocrinol. 177: 43–54

  • Davis LM, Caspary WJ, Sakallah SA, Maronpot R, Wiseman R, Barrett JC, Elliott R, Hozier JC . 1994 Carcinogenesis 15: 1637–1645

  • Dietrich WF, Miller JC, Steen RG, Merchant M, Damron D, Nahf R, Gross A, Joyce DC, Wessel M, Dredge RD, Marquis A, Stein LD, Goodman N, Page DC, Lander ES . 1994 Nat. Genet. 7: 220–245

  • Draper GJ, Sanders BM, Kingston JE . 1986 Br. J. Cancer 53: 661–671

  • Fletcher JA, Gebhardt MC, Kozakewich HP . 1994 Cancer Genet. Cytogenet. 77: 81–88

  • Fuchs N, Bielack SS, Epler D, Bieling P, Delling G, Korholz D, Graf N, Heise U, Jurgens H, Kotz R, Salzer-Kuntschik M, Weinel P, Werner M, Winkler K . 1998 Ann. Oncol. 9: 893–899

  • Gamberi G, Benassi MS, Bohling T, Ragazzini P, Molendini L, Sollazzo MR, Pompetti F, Merli M, Magagnoli G, Balladelli A, Picci P . 1998 Oncology 55: 556–563

  • Gossner W, Hug O, Luz A, Muller WA . 1976 Rec. Res. Cancer Res. 54: 36–49

  • Goto A, Kanda H, Ishikawa Y, Matsumoto S, Kawaguchi N, Machinami R, Kato Y, Kitagawa T . 1998 Jpn. J. Cancer Res. 89: 539–547

  • Hansen MF, Koufos A, Gallie BL, Phillips RA, Fodstad O, Brogger A, Gedde-Dahl T, Cavenee WK . 1985 Proc. Natl. Acad. Sci. USA 82: 6216–6220

  • Hatcher CJ, Kim MS, Mah CS, Goldstein MM, Wong B, Mikawa T, Basson CT . 2001 Dev. Biol. 230: 177–188

  • Kanoe H, Nakayama T, Murakami H, Hosaka T, Yamamoto H, Nakashima Y, Tsuboyama T, Nakamura T, Sasaki MS, Toguchida J . 1998 Anticancer Res. 18: 2317–2321

  • Kraus F, Haenig B, Kispert A . 2001 Mech. Dev. 100: 83–86

  • Kruzelock RP, Murphy EC, Strong LC, Naylor SL, Hansen MF . 1997 Cancer Res. 57: 106–109

  • Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH . 1993 Cancer Res. 53: 16–18

  • Lonardo F, Ueda T, Huvos AG, Healey J, Ladanyi M . 1997 Cancer 79: 1541–1547

  • Luz A, Muller WA, Linzner U, Strauss PG, Schmidt J, Muller K, Atkinson MJ, Murray AB, Gossner W, Erfle V, Höfler H . 1991 Radiat. Environ. Biophys. 30: 225–227

  • Malkin D, Li FP, Strong LC, Fraumeni Jr JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH . 1990 Science 250: 1233–1238

  • McCarthy LC, Terrett J, Davis ME, Knights CJ, Smith AL, Critcher R, Schmitt K, Hudson J, Spurr NK, Goodfellow PN . 1997 Genome Res. 7: 1153–1161

  • Mulligan LM, Matlashewski GJ, Scrable HJ, Cavenee WK . 1990 Proc. Natl. Acad. Sci. USA 87: 5863–5867

  • Nellissery MJ, Padalecki SS, Brkanac Z, Singer FR, Roodman GD, Unni KK, Leach RJ, Hansen MF . 1998 Am. J. Hum. Genet. 63: 817–824

  • Park WS, Park JY, Oh RR, Yoo NJ, Lee SH, Shin MS, Lee HK, Han S, Yoon SK, Kim SY, Choi C, Kim PJ, Oh ST, Lee JY . 2000 Cancer Res. 60: 70–73

  • Pompetti F, Rizzo P, Simon RM, Freidlin B, Mew DJ, Pass HI, Picci P, Levine AS, Carbone M . 1996 J. Cell. Biochem. 63: 37–50

  • Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ, Huvos AG, Betcher DL, Baum ES, Kisker CT, Miser JS . 1997 J. Clin. Oncol. 15: 76–84

  • Reardon DA, Entrekin RE, Sublett J, Ragsdale S, Li H, Boyett J, Kepner JL, Look AT . 1999 Genes Chromosomes Cancer 24: 230–237

  • Simons A, Janssen IM, Suijkerbuijk RF, Veth RP, Pruszczynski M, Hulsbergen-van de Kaa CA, du Manoir S, Geurts van Kessel A . 1997 Genes Chromosomes Cancer 20: 196–200

  • Simons A, Schepens M, Forus A, Godager L, van Asseldonk M, Myklebost O, van Kessel AG . 1999 Genes Chromosomes Cancer 26: 115–124

  • Stock C, Kager L, Fink FM, Gadner H, Ambros PF . 2000 Genes Chromosomes Cancer 28: 329–336

  • Tarkkanen M, Karhu R, Kallioniemi A, Elomaa I, Kivioja AH, Nevalainen J, Bohling T, Karaharju E, Hyytinen E, Knuutila S, Kallioniemi OP . 1995 Cancer Res. 55: 1334–1338

  • Toguchida J, Ishizaki K, Sasaki MS, Ikenaga M, Sugimoto M, Kotoura Y, Yamamuro T . 1988 Cancer Res. 48: 3939–3943

  • Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrera GE, Yamamuro T, Kotoura Y, Sasaki MS, Little JB, Weichselbaum RR, Ishizaki K, Yandell DW . 1992 Cancer Res. 52: 6194–6199

  • Van Etten WJ, Steen RG, Nguyen H, Castle AB, Slonim DK, Ge B, Nusbaum C, Schuler GD, Lander ES, Hudson TJ . 1999 Nat. Genet. 22: 384–387

  • Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y, Yamamuro T . 1994 Cancer Res. 54: 3042–3048

  • Wei G, Lonardo F, Ueda T, Kim T, Huvos AG, Healey JH, Ladanyi M . 1999 Int. J. Cancer 80: 199–204

  • Yamaguchi T, Toguchida J, Yamamuro T, Kotoura Y, Takada N, Kawaguchi N, Kaneko Y, Nakamura Y, Sasaki MS, Ishizaki K . 1992 Cancer Res. 52: 2419–2423

Download references

Acknowledgements

We thank Utz Linzner for oligonucleotide preparation and Wibke Wistrich for excellent technical assistance. Parts of this project were funded by grant F14P-CT95-0008 from the Radiation protection program of the European Union (M Rosemann) and from the Land Bayern (M Nathrath: HSP III) and the clinical research fund ‘KKF’ of the Technical University Munich (M Nathrath).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michaela H Nathrath.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nathrath, M., Kuosaite, V., Rosemann, M. et al. Two novel tumor suppressor gene loci on chromosome 6q and 15q in human osteosarcoma identified through comparative study of allelic imbalances in mouse and man. Oncogene 21, 5975–5980 (2002). https://doi.org/10.1038/sj.onc.1205764

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205764

Keywords

This article is cited by

Search

Quick links